Breadcrumbs Navigation

Home > Duke Magic: A History > Essays > Transforming Health Care at Duke and by Duke

Essay

Ralph Snyderman, MD, HS'65-'67
Transforming Health Care at Duke and by Duke
Transforming Health Care at Duke and by Duke
Excerpt

“. . . For academic medical centers, the 1990s were the best and the worst of times. It was an age of rapid and unsettling change in health care, largely brought about by the advent of for-profit managed care. It was also an age of great hope and excitement and a doubling of the NIH budget -- a most promising era in the history of biomedical research.

"And during that decade, Duke adapted to both of those forces, evolving into a very entrepreneurial, highly innovative new model that developed real-world solutions to health care problems. We revolutionized both our structure and our mindset, turning Duke into an academic engine that created new care-delivery and translational-research models that truly improved the health of society.”

In This Essay
  • Academic physician-scientist turned biotech industry pro returns to Duke to take the helm 
  • Game plan: Make Duke an innovator in biomedical research 
  • Crisis/opportunity: the advent of managed care 
  • Drs. Califf and Topol run clinical trials with GUSTO 
  • Unprecedented DCRI revitalizes clinical research, permits “unbiased and accurate analysis” 
  • The competition within: the battle for revenues amid incredible shrinking clinical margins 
  • Inventing the wheel: DUAP enables a “hubs and spokes” model 
  • Joint venture adventures 
  • Birth of a health system
Download the full essay as a pdf file
Ralph Snyderman, MD, HS'65-'67
Biography
Ralph Snyderman served as chancellor for health affairs and dean of the Duke University School of Medicine from 1989 to July 2004. He led the transition of the medical center into an internationally recognized leader of academic medicine, and oversaw the development of the Duke University Health System, one of the most successful integrated academic health systems in the country, serving as its first president and chief executive officer. He is a leading advocate for prospective care, a novel approach to personalized health and an evolving model of national health care delivery. Recent awards recognizing his contributions include the first Bravewell Leadership Award, Leadership in Personalized Medicine Award, Industrial Research Institutes Medal, Frost & Sullivan’s North American Health Care Lifetime Achievement Award, and Triangle Business Journal’s Healthcare Lifetime Achievement Award.

The views expressed within each of these essays are solely those of the author(s) and do not necessarily reflect the views of Duke University School of Medicine or Duke University Health System.